In the BioHarmony Drug Report Database
Empliciti (elotuzumab) is an antibody pharmaceutical. Elotuzumab was first approved as Empliciti on 2015-11-30. It is used to treat multiple myeloma in the USA. It has been approved in Europe to treat multiple myeloma. The pharmaceutical is active against SLAM family member 7.
Image (chem structure or protein)